{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-25-001204","form_type":"8-K","ticker":"LNAI","cik":"0001527728","company_name":"Lunai Bioworks Inc.","filed_at":"2025-09-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.231992+00:00","generated_at":"2026-05-17T07:56:21.705221+00:00","sec_items":["8.01","2.06"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Dutch court declares Lunai Bioworks subsidiary Gedi Cube B.V. bankrupt; impairment expected","bullets":["Court of Amsterdam declared Gedi Cube B.V. bankrupt on Sept 2, 2025, after voluntary petition.","Lunai expects material impairment charge in Q3 2025; amount not yet estimable.","Management implementing contingency plans to mitigate supply chain and project disruptions.","Neither Lunai nor its other subsidiaries have filed for bankruptcy; operations continue as usual.","Receiver Mr. M.M. Dellebeke appointed to oversee Gedi bankruptcy proceedings."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-25-001204","json":"https://secwatch.observer/filing/0001731122-25-001204.json","markdown":"https://secwatch.observer/filing/0001731122-25-001204.md","text":"https://secwatch.observer/filing/0001731122-25-001204.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1527728/000173112225001204/0001731122-25-001204-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1527728/000173112225001204/e6829_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T07:56:21.705221+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ae8f3829a38defb6f5113918a01e779a5e244fa1","claim":"Lunai Bioworks Inc. announced a impairment.","evidence_excerpt":"management determined on September 2, 2025 that a material impairment of assets has occurred. The Company expects to record an impairment charge for the quarter ending September 30, 2025, however, is unable to make a good faith estimate of the same or the cash expenditures resulting from the impairment charge, if any, at the time of this filing.","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1527728/000173112225001204/0001731122-25-001204-index.htm","confidence":0.4,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"impairment"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}